Mystakidou, MD, PhD, K., Katsouda, MD, E., Parpa, BA, MA, E., Tsiatas, MD, PhD, M. L., & Vlahos, MD, PhD, L. (2005). Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. Journal of Opioid Management, 1(1), 36–40. https://doi.org/10.5055/jom.2005.0010